| PUBCHEM ID |
25078000
|
| UNII |
5ITA1WU19R
|
| Preferred Term |
CYCLOPOSINE
|
| CAS |
23185-94-6
|
| INCHIKEY |
OSOOWXRUSUHLOX-PBFVMIKGSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C[C@@H]1[C@@](CC2)(C(C)=C(C3)[C@H]2[C@@H]2[C@@H]3[C@](C)(CC[C@H](C3)O[C@H]([C@H]([C@@H]4O)O)O[C@@H](CO)[C@@H]4O)C3=CC2)O[C@@H]2[C@@H]1NC[C@H](C)C2
|
| Total Surface Area |
403,45
|
| Relative PSA |
0,23264
|
| TPSA |
120,64
|
| cLogS |
-4,693
|
| MW |
573,768
|
| cLogP |
2,4925
|
| H-Acceptors |
8
|
| H-Donors |
5
|
| Ro5 violations |
1
|
| Druglikeness |
-2,0083
|
| DrugScore |
0,273968602909866
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,2658
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,185
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5256
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
3,0868
|
| Carcinogenicity (Three-class) |
Non-required
|